Introduction to immunotherapy in cancer Educational session

Immune checkpoints: Do we really know how they work? (ID 234)

Lecture Time
11:55 - 12:15
Speakers
  • J. B. Haanen (Amsterdam, Netherlands)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
11:15 - 12:45
Authors
  • J. B. Haanen (Amsterdam, Netherlands)
Introduction to immunotherapy in cancer Educational session

Back to the basics (ID 232)

Lecture Time
11:15 - 11:35
Speakers
  • P. Romero (Epalinges, Switzerland)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
11:15 - 12:45
Authors
  • P. Romero (Epalinges, Switzerland)
Introduction to immunotherapy in cancer Educational session

DOI (ID 503)

Lecture Time
11:15 - 11:15
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
11:15 - 12:45
Introduction to immunotherapy in cancer Educational session

How to combine with I-O drugs (ID 235)

Lecture Time
12:15 - 12:35
Speakers
  • J. B. Haanen (Amsterdam, Netherlands)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
11:15 - 12:45
Authors
  • J. B. Haanen (Amsterdam, Netherlands)
Introduction to immunotherapy in cancer Educational session

Biomarkers (ID 233)

Lecture Time
11:35 - 11:55
Speakers
  • K. M. Kerr (Aberdeen, United Kingdom)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
11:15 - 12:45
Authors
  • K. M. Kerr (Aberdeen, United Kingdom)
Introduction to immunotherapy in cancer Educational session

General discussion / Q&A (ID 236)

Lecture Time
12:35 - 12:45
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
11:15 - 12:45
Opening and welcome Educational session

Welcome to the Congress (ID 2)

Lecture Time
13:30 - 13:45
Speakers
  • G. Coukos (Epalinges, Switzerland)
  • J. B. Haanen (Amsterdam, Netherlands)
Session Name
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
13:30 - 13:45
Authors
  • G. Coukos (Epalinges, Switzerland)
  • J. B. Haanen (Amsterdam, Netherlands)

Abstract

Background

test
est
tes
tset

Methods

testtesttesttesttestvtest

Results

test testtesttesttesttesttesttesttesttestv

Conclusions

The character limit for all submitted abstracts is set to a total of 2,000, excluding spaces. This overall limit includes characters entered in the title, abstract body sections and table (default of 225 characters) but not the author names, keywords and institutions. You do NOT need to enter the section title (eg: "Conclusions") as this is automatically formatted and by doing so you will reduce your available character limit.The character limit for
Collapse
Opening keynote - Award lecture Keynote Lecture

Combination immunotheraphy of cancers caused by high-risk human papillomavirus (ID 495)

Lecture Time
13:45 - 14:15
Speakers
  • C. J. Melief (Leiden, Netherlands)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
13:45 - 14:15
Authors
  • C. J. Melief (Leiden, Netherlands)
Opening keynote - Award lecture Keynote Lecture

DOI session (ID 506)

Lecture Time
13:45 - 13:45
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
13:45 - 14:15
Adoptive T cell therapy Educational session

General discussion / Q&A (ID 14)

Lecture Time
15:50 - 16:00
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
14:30 - 16:00
Adoptive T cell therapy Educational session

New directions in CAR therapy (ID 12)

Lecture Time
15:10 - 15:30
Speakers
  • F. Thistlethwaite (Manchester, United Kingdom)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
14:30 - 16:00
Authors
  • F. Thistlethwaite (Manchester, United Kingdom)
Adoptive T cell therapy Educational session

TCR based adoptive immunotherapy (ID 10)

Lecture Time
14:30 - 14:50
Speakers
  • T. Blankenstein (Berlin, Germany)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
13.12.2018
Time
14:30 - 16:00
Authors
  • T. Blankenstein (Berlin, Germany)